California to Launch $11 State-Brand Insulin Under CalRx Initiative
California will start selling its own affordable insulin under the CalRx brand on Jan. 1, aiming to lower costs for diabetics, with prices as low as $11 per pen, as part of a broader effort to reduce prescription drug prices and increase access to essential medications.
